DE69123848T2 - Stabile sauerstoff-freie reagenzienlösung für diagnostik - Google Patents

Stabile sauerstoff-freie reagenzienlösung für diagnostik

Info

Publication number
DE69123848T2
DE69123848T2 DE69123848T DE69123848T DE69123848T2 DE 69123848 T2 DE69123848 T2 DE 69123848T2 DE 69123848 T DE69123848 T DE 69123848T DE 69123848 T DE69123848 T DE 69123848T DE 69123848 T2 DE69123848 T2 DE 69123848T2
Authority
DE
Germany
Prior art keywords
reagent
reagent solution
diagnostics
stable oxygen
free reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69123848T
Other languages
English (en)
Other versions
DE69123848D1 (de
Inventor
Louis Saldivar
Barbara England
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69123848D1 publication Critical patent/DE69123848D1/de
Publication of DE69123848T2 publication Critical patent/DE69123848T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G01N2333/675—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin beta-Endorphins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/80—Multi-analyte reference solutions containing cholesterol, glucose and the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/801—Anerobic cultivation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/146666—Bile pigment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69123848T 1990-10-22 1991-10-18 Stabile sauerstoff-freie reagenzienlösung für diagnostik Expired - Fee Related DE69123848T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60079790A 1990-10-22 1990-10-22
PCT/US1991/007629 WO1992007088A1 (en) 1990-10-22 1991-10-18 Stabilized anoxic diagnostic reagent solution

Publications (2)

Publication Number Publication Date
DE69123848D1 DE69123848D1 (de) 1997-02-06
DE69123848T2 true DE69123848T2 (de) 1997-07-10

Family

ID=24405090

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69123848T Expired - Fee Related DE69123848T2 (de) 1990-10-22 1991-10-18 Stabile sauerstoff-freie reagenzienlösung für diagnostik

Country Status (9)

Country Link
US (1) US5401639A (de)
EP (1) EP0541729B1 (de)
AT (1) ATE146821T1 (de)
AU (1) AU8874591A (de)
DE (1) DE69123848T2 (de)
DK (1) DK0541729T3 (de)
ES (1) ES2098377T3 (de)
GR (1) GR3022831T3 (de)
WO (1) WO1992007088A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296377A (en) * 1992-12-15 1994-03-22 Boehringer Mannheim Corporation Control reagent containing a hydroxylamine or an antioxidant
KR970022316A (ko) * 1995-10-27 1997-05-28 후루야 아끼라 빌리루빈의 정량 방법
ATE225515T1 (de) * 1996-03-22 2002-10-15 Roche Diagnostics Gmbh Stabilisierung von bilirubin in kontrollseren und kalibratoren
US7374905B2 (en) * 2000-11-08 2008-05-20 Oxyrase, Inc. Medium composition, method and device for selectively enhancing the isolation of anaerobic microorganisms contained in a mixed sample with facultative microorganisms
GB0207533D0 (en) 2002-04-02 2002-05-08 Oxford Glycosciences Uk Ltd Protein
AU2005282773B2 (en) * 2004-09-01 2010-07-08 Maine Standards Company, Llc Stable lipid standards
KR100579467B1 (ko) 2005-04-18 2006-05-15 (주)메드멕스 세포학적 진단을 위한 보조용액
EP2447719B1 (de) 2007-02-26 2016-08-24 Oxford BioTherapeutics Ltd Proteine
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
WO2010084408A2 (en) 2009-01-21 2010-07-29 Oxford Biotherapeutics Ltd. Pta089 protein
US20120282177A1 (en) 2009-11-02 2012-11-08 Christian Rohlff ROR1 as Therapeutic and Diagnostic Target
WO2013001369A2 (en) 2011-06-28 2013-01-03 Oxford Biotherapeutics Ltd. Therapeutic and diagnostic target
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1095819A (en) * 1977-01-14 1981-02-17 Eastman Kodak Company Element for analysis of liquids
US4414334A (en) * 1981-08-07 1983-11-08 Phillips Petroleum Company Oxygen scavenging with enzymes
US4476224A (en) * 1982-05-10 1984-10-09 Adler Howard I Material and method for promoting the growth of anaerobic bacteria
JPS6040957A (ja) * 1983-08-15 1985-03-04 Toyobo Co Ltd 抱合型ビリルビンの安定化法
US4775626A (en) * 1986-05-23 1988-10-04 Syntex (U.S.A.) Inc. Method and compositions for protecting anerobic microorganisms
US5047395A (en) * 1990-07-17 1991-09-10 Nagase Co., Ltd. Reduction of oxyradical damage in biomedical applications

Also Published As

Publication number Publication date
GR3022831T3 (en) 1997-06-30
ATE146821T1 (de) 1997-01-15
DK0541729T3 (da) 1997-06-02
AU8874591A (en) 1992-05-20
ES2098377T3 (es) 1997-05-01
DE69123848D1 (de) 1997-02-06
WO1992007088A1 (en) 1992-04-30
EP0541729A1 (de) 1993-05-19
US5401639A (en) 1995-03-28
EP0541729A4 (en) 1994-09-28
EP0541729B1 (de) 1996-12-27

Similar Documents

Publication Publication Date Title
ATE146821T1 (de) Stabile sauerstoff-freie reagenzienlösung für diagnostik
CA2079748C (en) Hydrophilic polyurethane membranes for electrochemical glucose sensors
EP0020788A4 (de) Testprobe zum messen von glukose.
DE60018386D1 (de) Station zur nukleinsäurevervielfältigung für wegwerftestträger
FI870136A0 (fi) Stabil komposition foer bestaemning av peroxidativt aktiva aemnen.
ES291678U (es) Sonda de dialisis principalmente prevista para su insercion en tejidos biologicos
DE69622700T2 (de) Homogene polymerzusammensetzungen die silicon enthalten für biosensormembranen
ATE368385T1 (de) Molkereistarterkultur-abgabesystem und dessen verwendung
GB1525628A (en) Chemical immobilization of enzymes
DE3882078D1 (de) Amperometrische methode zur titration von nadh (1,4-dihydronicotinamid-adenine-dinucleotide) in loesung.
IE56986B1 (en) Improvements in business forms assemblies
NO874783L (no) Fremgangsmaate for mengdebestemmelse av stabilt, glycosylert hemoglobin.
Schleser Oxygen isotope fractionation during respiration for different temperatures of T. utilis and E. coli K12
DK375188A (da) Fremgangsmaade til fremstilling af et biologisk aktivt kompleks og det fremstillede kompleks
DE3473475D1 (en) Process for determining substrate or enzymatic activity
BR0114113A (pt) Ativador para um fermento à base de bactérias lácteas, utilização do mesmo, fermento ativado à base de bactérias lácteas, e, processo para a preparação de um produto lácteo
Saldivar et al. Stabilized bilirubin calibrator solution and method therefor
JPS6273150A (ja) ２方向の拡散を行うグルコ−ス基質感応電極
EP0206277A1 (de) Mediumzusammensetzung zur Identifikation von Mikroorganismen
Brasseur et al. Conformational analysis of the calcium-antagonist gallopamil
Karnauchow et al. Experience with SI units in biochemistry.
Kirchheimer Examination of North American Armadillos for mycobacteriosis--a further report
ATE80893T1 (de) 17-halogenmethylen-estratriene.
Zhong THE CLINICAL RALATlONSHIP OF CHRONIC SUPPURATIVE OTITIS MEDIA (CSOM) WITH LPHASE-BACTERIA AND ANAEROBIC INFECTIONS
Hutchinson et al. HIV infection in a psychiatric hospital-abstract

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee